Orthobiologics

Bone Solutions reached the milestone of 50 successful implants of OsteoCrete® magnesium-based bone void filler....

Orthocell was granted an Australian patent, "Sutureless repair of soft tissue," addressing the CelGro® collagen medical device platform. ...

MiMedx commenced enrollment in a Phase III Investigational New Drug clinical trial of AmnioFix® Injectable in the treatment of Achilles Tendonitis....

ORTHOReBIRTH USA received FDA 510(k) clearance to market ReBOSSIS® biosynthetic bone scaffold for use in posterolateral spine procedures....

FzioMed marked the worldwide sale of 500,000 units of its Oxiplex® viscoelastic hydrogel....

Anika Therapeutics received FDA 510(k) clearance to market a resorbable, injectable hyaluronic acid-based bone void filler....

Zimmer Biomet announced positive results in a pilot study demonstrating safety and promising efficacy from use of the nSTRIDE® Autologous Protein Solution Kit to...

Preclinical study results indicate that Bone Biologics’ rhNELL-1 growth factor effectively promoted bone formation in a spine model....

HSS researchers have been awarded an $800,000 grant from OREF to support a clinical trial on the use of stem cell...

Orthocell was granted a European Patent covering the manufacture of tendon regeneration cells used to form the Ortho-ATI® Autologous Tenocyte...